Tecnologías sanitarias
Empresas argentinas dedicadas a un sector: tecnologías sanitarias
Estas Empresas argentinas operan en el mismo sector, tecnologías sanitarias. Incluyen el precio, el cambio y otras estadísticas para ayudarle a obtener la máxima información. La lista contiene acciones para cualquier tipo de estrategia: desde colosos de gran capitalización como ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), las principales ganadoras como AMGEN INC CEDEAR EACH 30 REP 1 y muchas más. Filtre la lista y compruebe el rendimiento de las empresas según le convenga.
Símbolo | Capitalización de mercado | Precio | Cambio % | Volumen | Volumen relativo | P/B | BPA dil. TTM | Crecimiento BPA dil. TTM YoY | Rendimiento del dividendo % TTM | Calificación de los analistas |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 745,24 T ARS | 14,050 USD | +2,93% | 222 | 0,46 | 109,04 | 124,85 ARS | +178,70% | 0,34% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 745,24 T ARS | 15.925,000 ARS | +2,58% | 8,89 K | 1,33 | 127,55 | 124,85 ARS | +564,33% | 0,34% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 355,65 T ARS | 9,790 USD | −1,51% | 561 | 0,23 | 30,91 | 306,92 ARS | +50,08% | 1,75% | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 355,65 T ARS | 11.150,000 ARS | +0,68% | 8,42 K | 0,19 | 36,33 | 306,92 ARS | +257,75% | 1,75% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 355,65 T ARS | 1.300,000 ARS | 0,00% | 15 | 1,90 | — | — | — | — | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 317,25 T ARS | 17,900 USD | +1,70% | 70 | 0,50 | 7,40 | 2.343,37 ARS | +18,73% | 1,72% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 317,25 T ARS | 20.375,000 ARS | +2,39% | 497 | 0,70 | 8,69 | 2.343,37 ARS | +183,01% | 1,72% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 253,61 T ARS | 20,600 USD | −4,19% | 31 | 0,56 | 22,60 | 883,37 ARS | +319,19% | 1,52% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 253,61 T ARS | 22.850,000 ARS | −0,22% | 1,07 K | 0,44 | 25,87 | 883,37 ARS | +899,22% | 1,52% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 204,96 T ARS | 27.475,000 ARS | +0,92% | 39,03 K | 53,24 | 49,16 | 558,94 ARS | +251,94% | 0,14% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 203,27 T ARS | 33,150 USD | +1,53% | 11 | 0,95 | 47,39 | 677,80 ARS | +64,44% | 1,51% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 203,27 T ARS | 38.000,000 ARS | +2,01% | 373 | 0,23 | 56,06 | 677,80 ARS | +291,99% | 1,51% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 202,58 T ARS | 29,600 USD | +1,54% | 3 | 0,13 | 45,53 | 629,98 ARS | +55,55% | 0,94% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 202,58 T ARS | 33.125,000 ARS | +1,69% | 143 | 0,40 | 52,58 | 629,98 ARS | +270,79% | 0,94% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 195,36 T ARS | 25,000 USD | −11,97% | 2 | 1,05 | 2,79 | 8.672,72 ARS | +140,89% | 3,81% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 195,36 T ARS | 28.275,000 ARS | +1,25% | 232 | 0,45 | 3,26 | 8.672,72 ARS | +474,20% | 3,81% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 190,99 T ARS | 6.990,000 ARS | 0,00% | 143 | 3,45 | 132,16 | 52,89 ARS | +386,62% | 0,00% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 168,79 T ARS | 4.875,000 ARS | +2,63% | 485 | 2,22 | 66,09 | 73,76 ARS | +137,74% | 0,00% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 152,74 T ARS | 6,720 USD | +2,75% | 1,91 K | 0,67 | 27,74 | 234,71 ARS | +35,96% | 3,23% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 152,74 T ARS | 7.660,000 ARS | +3,51% | 27,81 K | 0,89 | 32,64 | 234,71 ARS | +224,10% | 3,23% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 144,76 T ARS | 8,500 USD | −2,86% | 45 | 0,89 | 33,07 | 249,09 ARS | −66,41% | 2,37% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 144,76 T ARS | 10.350,000 ARS | +3,81% | 2,65 K | 2,51 | 41,55 | 249,09 ARS | −19,94% | 2,37% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 118,89 T ARS | 20,600 USD | +0,98% | 5 | 0,56 | — | −1.078,84 ARS | −253,68% | 2,11% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 118,89 T ARS | 21.875,000 ARS | +0,92% | 462 | 1,09 | — | −1.078,84 ARS | −466,33% | 2,11% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 117,96 T ARS | 24,500 USD | +2,94% | 4 | 0,24 | — | −50,65 ARS | −107,71% | 1,58% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 117,96 T ARS | 26.875,000 ARS | +2,97% | 400 | 1,56 | — | −50,65 ARS | −118,38% | 1,58% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 106,24 T ARS | 23.500,000 ARS | +1,62% | 112 | 0,25 | 34,95 | 672,48 ARS | +274,72% | 1,97% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 68,86 T ARS | 8,750 USD | +0,11% | 6 | 0,06 | 27,54 | 307,84 ARS | −37,30% | 3,34% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 68,86 T ARS | 9.860,000 ARS | +2,39% | 293 | 0,12 | 32,03 | 307,84 ARS | +49,45% | 3,34% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 23,88 T ARS | 5.840,000 ARS | +1,74% | 133 | 0,67 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 21,82 T ARS | 11,450 USD | −3,78% | 2 | 0,15 | 15,95 | 695,64 ARS | +96,62% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 21,82 T ARS | 13.075,000 ARS | −0,19% | 241 | 0,28 | 18,80 | 695,64 ARS | +368,68% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 15,5 T ARS | 2,180 USD | −0,91% | 1 | 0,01 | — | −262,17 ARS | +31,39% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 15,5 T ARS | 2.425,000 ARS | +0,41% | 2,88 K | 0,59 | — | −262,17 ARS | −63,54% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 140,91 B ARS | 1.745,000 ARS | +2,65% | 9,73 K | 0,67 | 18,12 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5,11 B ARS | 120,000 ARS | 0,00% | 1,84 K | 0,18 | 28,11 | 4,27 ARS | +64,50% | 0,00% | — |